High performance liquid chromatography (HPLC) – mass spectrometry method. Pharmacokinetic parameters AUC0-t, AUC0-∞ and Cmax were tested for bioequivalence after log-transformation of data and ratios of tmax were…
under the plasma concentration curve (AUC) over infinite time (AUCinf) and peak plasma concentration (Cmax) were determined for aripiprazole administered alone and coadministered with desvenlafaxine. Lack of an…
were determined by non-compartmental method. The mean value of the peak plasma concentration (Cmax) of tizanidine decreased significantly (8.47%, P value <0.001; 90% CI, 91.32% -91.72%) in animals ... given the drug…
plasma concentration–time curves were used to obtain pharmacokinetic parameters including AUC0–t, AUC0–∞, Cmax and Tmax. The criteria for bioequivalence were ... Cmax, and no significant differences for Tmax with a…
presence of Tansulosina as internal standard. The mean ratio of parameters Cmax and AUC0-t and 90% confidence intervals of correspondents were calculated to determine the bioequivalence. The means AUC0 ... pg.h/mL, for…
over the world with orally inhaled drugs (OIDs). The traditional pharmacokinetic approaches (AUC and Cmax determination) are currently not accepted by the FDA for evaluating the Inhalations drugs equivalence ... lung…
over the world with orally inhaled drugs (OIDs). The traditional pharmacokinetic approaches (AUC and Cmax determination) are currently not accepted by the FDA for evaluating the Inhalations drugs equivalence ... lung…
blood samples were collect- ed throughout 36 hours. Th e AUC0-36 , AUC0-_, Cmax and Tmax were calculated. Bioequiva- lence was concluded if the 90% confi dence interval ... ratios for area under the curve (AUC) and peak…
UPLC-MS/MS method. The pharmacokinetic parameters such as AUC0-t, AUC0-â??, Cmax, Tmax and t1/2, were analyzed. Analysis of variance was carried out using logarithmically transformed AUC0 ... AUC0-â?? and Cmax. The…
other brand having similar composition while fasting. To assess Pharmacokinetic (PK) characteristics, such as Cmax and Tmax, 25 blood samples were taken over an interval of 96 hours after ... Results: All 14…
assess Pharmacokinetics (PK) and safety. The primary PK endpoints for demonstration of BE were Cmax , AUClast , and AUCinf of BCV in plasma. BE was declared if the 90% Confidence Interval ... completed all study visits…
plasma concentration vs time curve (AUC0-4h) for amino acids. The secondary endpoints included: Cmax, Tmax, incidence of acneiform lesions, and safety. Results: Of 30 participants, 26 were treated ... plasma amino acid…
tablets was done by comparing the pharmacokinetic parameters: Cmax, AUC0-t and AUC0-∞. Results: 17 subjects were evaluated in the study with the lower strength (400 mg) and 43 subjects ... geometric mean in study 1 were…
pharmacokinetics / pharmacodynamics (PK/PD) ratios must be achieved i.e., that the maximum serum concentration (CMAX) reach a peak at or above 10 to 12 times the value of the minimum ... inhibitory concentration (MIC)…
transformed mean values of the test/reference ratios for the pharmacokinetic parameters (Cmax), (AUC0-t), and the (AUC0-âˆÅ¾) were calculated. The pharmacokinetic parameters from the UV-Vis analytical method…
Chromatography (UPLC-MS/MS) with a validated method. Logarithmic ratios of maximal plasma Concentration (Cmax) and Area under the Curve (AUC0-24h) were used to establish 90% Confidence Intervals ... accuracy and…
each phase and concentration determined by the spectrophotometric method. Pharmacokinetics parameters determined include Cmax, Tmax, t1/2α, ClT, AUC0-9, AUC 0-∞, t1/2β and kβ. The in-silico studies ... line with…
each phase and concentration determined by the spectrophotometric method. Pharmacokinetics parameters determined include Cmax, Tmax, t1/2α, ClT, AUC0-9, AUC 0-∞, t1/2β and kβ. The in-silico studies ... line with…
felodipine formulations and pharmacokinetic studies of human plasma were conducted. Pharmacokinetic parameters such as Cmax, Tmax, AUC(0-t), AUC(0-∞), Keli and t½ were calculated and the blood plasma ... test product…
dose of the test alfuzosin tablet and completed the clinical study. The pharmacokinetic parameters Cmax and AUC0â??t, Kel, AUC0â??â??, tmax, t1/2el were estimated to prove bioequivalence ... transformed Test/Reference…
decided byHPLC method. From the time Vs plasmaconcentration data various pharmacokineticparameters like peak concentration (Cmax), time atwhich peak occurred (Tmax), area under the curve(AUC), elimination rate constant…
using respective methods for 28 days. The obtained pharmacokinetic data shows an increase in Cmax, Tmax, AUCtotal, AUC0-n, t½, MRT and decrease in Vd and CL in both normal
extract (1 g/kg) resulted in marked reductions (62.1% decrease) in the maximum concentration (Cmax) and increases (6-fold) in the time to reach a Cmax (Tmax), respectively, as compared ... different between two groups…
bioavailability of both drugs in combination (94% for carvedilol and 58% for ivabradine. Also, Cmax was changed significantly by 165% for carvedilol and 56% for ivabradine, when given in combination